88 related articles for article (PubMed ID: 2927156)
21. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
Zell JA; Ou SH; Ziogas A; Anton-Culver H
Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
[TBL] [Abstract][Full Text] [Related]
22. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
Liao ML; Zhou YZ; Ding JA; Ni GX; Zhao JM; Chen WH; Han BH; Shen J; Bai H; Chen ZW; Ji H; Wang HM; Zhou Z
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):962-6. PubMed ID: 12899797
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
[TBL] [Abstract][Full Text] [Related]
24. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
25. Stage II and III-A non-small cell cancer of the lung: results of surgical resection at Fairfax Hospital.
Kiernan PD; Sheridan M; Byrne WD; Fulcher T; Attai D; Seigel L; Hull M
Va Med Q; 1994; 121(3):172-8. PubMed ID: 8061068
[TBL] [Abstract][Full Text] [Related]
26. Is follow-up of lung cancer patients after resection medically indicated and cost-effective?
Walsh GL; O'Connor M; Willis KM; Milas M; Wong RS; Nesbitt JC; Putnam JB; Lee JJ; Roth JA
Ann Thorac Surg; 1995 Dec; 60(6):1563-70; discussion 1570-2. PubMed ID: 8787445
[TBL] [Abstract][Full Text] [Related]
27. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.
Pfannschmidt J; Muley T; Bülzebruck H; Hoffmann H; Dienemann H
Lung Cancer; 2007 Mar; 55(3):371-7. PubMed ID: 17123661
[TBL] [Abstract][Full Text] [Related]
28. [Survival rate of 2636 patients with bronchogenic carcinoma].
Liao ML
Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):34-7. PubMed ID: 2843332
[TBL] [Abstract][Full Text] [Related]
29. [Assessment of a new TNM classification produced by UICC for resected lung cancer with intrapulmonary satellite tumor(s)].
Usuda K; Saito Y; Sato M; Sakuma T; Aikawa H; Takahashi H; Okaniwa G; Handa M; Takahashi S; Fujimura S
Nihon Kyobu Geka Gakkai Zasshi; 1996 May; 44(5):629-33. PubMed ID: 8964991
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of 64 second primary cancers of the bronchi].
Roeslin N; Wintringer P; Vergeret J; Taytard A; Witz JP
Ann Chir; 1989; 43(2):125-9. PubMed ID: 2712494
[TBL] [Abstract][Full Text] [Related]
31. [Multiple primary lung cancers. The importance of early diagnosis and survival after a new surgical excision].
Mousset X; Deslauriers J; Beaulieu M; Després JP; Piraux M; Fournier B; Lavallée J; Saint-Pierre C
Ann Chir; 1989; 43(8):658-62. PubMed ID: 2589800
[TBL] [Abstract][Full Text] [Related]
32. [Prognosis of inoperable non-small cell bronchial cancer].
Kjelsberg F; Mellem H; Vale JR; Johansen B
Tidsskr Nor Laegeforen; 1991 Jan; 111(2):186-8. PubMed ID: 1705368
[TBL] [Abstract][Full Text] [Related]
33. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis.
Suzuki K; Nagai K; Yoshida J; Yokose T; Kodama T; Takahashi K; Nishimura M; Kawasaki H; Yokozaki M; Nishiwaki Y
Cancer; 1997 Apr; 79(8):1521-6. PubMed ID: 9118033
[TBL] [Abstract][Full Text] [Related]
34. The role of prophylactic lung cancer irradiation in patients (with stage M1 disease) without chest symptoms.
Ampil FL
Radiat Med; 1991; 9(4):142-5. PubMed ID: 1961938
[TBL] [Abstract][Full Text] [Related]
35. [Controversies in the new TNM staging system].
Kondo K; Monden Y
Nihon Geka Gakkai Zasshi; 1999 Nov; 100(11):700-4. PubMed ID: 10629834
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of skin reactivity in patients with bronchogenic carcinoma grouped according to the TNM classification.
Plesnicar S; Rudolf Z; Lavrencic D
Neoplasma; 1977; 24(6):633-40. PubMed ID: 593468
[TBL] [Abstract][Full Text] [Related]
37. [Comparative survival study between the old and new bronchogenic carcinoma classification].
Martínez-Somolinos S; Rubio-Garay MM; Mármol-Cazas EE; Baldó-Padró X; Penagos-Tafurt JC; Sebastián-Quetglás F; García-Gil Mdel M
Cir Esp; 2011 Oct; 89(8):539-45. PubMed ID: 21458781
[TBL] [Abstract][Full Text] [Related]
38. Multiple primary bronchogenic carcinomas: treatment and follow-up.
Fleisher AG; McElvaney G; Robinson CL
Ann Thorac Surg; 1991 Jan; 51(1):48-51. PubMed ID: 1985573
[TBL] [Abstract][Full Text] [Related]
39. Asymptomatic solitary pulmonary nodules. Host survival, tumor size, and growth rate.
Steele JD; Buell P
J Thorac Cardiovasc Surg; 1973 Jan; 65(1):140-51. PubMed ID: 4682461
[No Abstract] [Full Text] [Related]
40. Intrapulmonary satellite nodule of lung cancer as a T factor.
Yano M; Arai T; Inagaki K; Morita T; Nomura T; Ito H
Chest; 1998 Nov; 114(5):1305-8. PubMed ID: 9824006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
